← Back to Search
Antineoplastic Therapy Use In Patients With Advanced Cancer Admitted To An Acute Palliative Care Unit At A Comprehensive Cancer Center
D. Hui, A. Elsayem, Z. Li, M. de la Cruz, J. Palmer, E. Bruera
Published 2010 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Cancer patients admitted to a palliative care unit generally have a poor prognosis. The role of antineoplastic therapy (ANT) in these patients remains controversial. In the current study, the authors examined the frequency and predictors associated with ANT use in hospitalized patients who required admission to an acute palliative care unit (APCU).
This paper references
Acute Inpatient Palliative Medicine in a Cancer Center: Clinical Problems and Medical Interventions—A Prospective Study
R. Lagman (2007)
On How Increasing Numbers of Newer Cancer Therapies Further Delay Referral to Hospice: The Increasing Palliative Care Imperative
D. Mintzer (2007)
Identifying potential indicators of the quality of end-of-life cancer care from administrative data.
C. Earle (2003)
Palliative medicine review: prognostication.
P. Glare (2008)
Palliative care inpatient service in a comprehensive cancer center: clinical and financial outcomes.
A. Elsayem (2004)
Are chemotherapy response rates related to treatment-induced survival prolongations in patients with advanced cancer?
T. Shanafelt (2004)
Advanced breast cancer patients' perceptions of decision making for palliative chemotherapy.
E. Grunfeld (2006)
Integration of a palliative and terminal care center into a comprehensive pediatric oncology department
H. Golan (2008)
Measuring supportive care in medical oncology practice: lessons learned from the quality oncology practice initiative.
K. McNiff (2008)
Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer.
P. Geels (2000)
Predictors of access to palliative care services among Original Article 2042 Cancer April 15, 2010 patients who died at a comprehensive cancer center
N Fadul (2007)
Physician factors in the timing of cancer patient referral to hospice palliative care
E. Lamont (2002)
Edmonton symptom assessment scale: Italian validation in two palliative care settings
C. Moro (2005)
Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer.
R. Matsuyama (2006)
Barriers to hospice enrollment among lung cancer patients: a survey of family members and physicians.
D. Ford (2008)
Interval between palliative care referral and death among patients treated at a comprehensive cancer center.
W. Cheng (2005)
Palliative chemotherapy: historical perspective, applications, and controversies.
I. Browner (2005)
The use of the Edmonton Symptom Assessment Scale (ESAS) within a palliative care unit in the UK
E. Rees (1998)
Simultaneous care: disease treatment and palliative care throughout illness.
F. Meyers (2003)
Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer.
C. Doyle (2001)
Chemotherapy for advanced breast cancer: what influences oncologists' decision-making?
E. Grunfeld (2001)
Palliative chemotherapy or watchful waiting? A vignettes study among oncologists.
C. Koedoot (2002)
Simultaneous care: a model approach to the perceived conflict between investigational therapy and palliative care.
F. Meyers (2004)
Quality of end-of-life treatment for cancer patients in general wards and the palliative care unit at a regional cancer center in Japan: a retrospective chart review
K. Sato (2007)
Palliative chemotherapy or best supportive care? A prospective study explaining patients' treatment preference and choice
C. Koedoot (2003)
Some elements of prognosis in terminal cancer.
E. Lamont (1999)
Prognostic factors in advanced cancer patients: evidence-based clinical recommendations--a study by the Steering Committee of the European Association for Palliative Care.
M. Maltoni (2005)
Identifying prognostic factors for survival in advanced cancer patients: a prospective study.
P. Lam (2007)
Terminal cancer patients and timing of referral to palliative care: a multicenter prospective cohort study. Italian Cooperative Research Group on Palliative Medicine.
M. Costantini (1999)
Predictors of access to palliative care services among patients who died at a Comprehensive Cancer Center.
N. Fadul (2007)
The role of chemotherapy at the end of life: "when is enough, enough?".
Sarah E. Harrington (2008)
Integration of palliative medicine into comprehensive cancer care.
R. Lagman (2005)
Quality of life assessment and outcome of palliative care.
E. Paci (2001)
Nonparametric Estimation from Incomplete Observations
E. L. Kaplan (1958)
Acute Physiology and Chronic Health Evaluation (APACHE) IV: Hospital mortality assessment for today’s critically ill patients*
J. Zimmerman (2006)
Are We Making Progress? Not in Haematology!
P. Mcgrath (2002)
A National Framework and Preferred Practices for Palliative and Hospice Care Quality
Cancer care during the last phase of life.
D. S. Gordon (1998)
This paper is referenced by
The Frequency and Correlates of Spiritual Distress Among Patients With Advanced Cancer Admitted to an Acute Palliative Care Unit
D. Hui (2011)
The Importance of Palliative Care in Patient Therapy
Angela R. Bova (2017)
Targeted agent use in cancer patients at the end of life.
D. Hui (2013)
Reduced use of chemotherapy at the end of life in an integrated-care model of oncology and palliative care
Roberto Magarotto (2011)
Preclinical trial of the multi-targeted lenvatinib in combination with cellular immunotherapy for treatment of renal cell carcinoma.
C. Cai (2017)
Symptom Expression in the Last Seven Days of Life Among Cancer Patients Admitted to Acute Palliative Care Units.
D. Hui (2015)
Palliative Care in Critically Ill Cancer Patients
Ali Haider (2019)
Palliative Care in Cervical Cancer Patients
S. Allende-Pérez (2017)
Metastasis-associated protein 2 promotes the metastasis of non-small cell lung carcinoma by regulating the ERK/AKT and VEGF signaling pathways
Bin Zhang (2018)
Quality of end‐of‐life care in patients with hematologic malignancies: A retrospective cohort study
D. Hui (2014)
Timing of palliative care referral and symptom burden in phase 1 cancer patients
D. Hui (2010)
Differences in attitudes and beliefs toward end-of-life care between hematologic and solid tumor oncology specialists.
D. Hui (2015)
Bedside clinical signs associated with impending death in patients with advanced cancer: Preliminary findings of a prospective, longitudinal cohort study
D. Hui (2015)
Higher complication risk of totally implantable venous access port systems in patients with advanced cancer – a single institution retrospective analysis
Y. Chang (2013)
Correction to: Can early palliative care with anticancer treatment improve overall survival and patient-related outcomes in advanced lung cancer patients? A review of the literature
M. Ambroggi (2018)
Acute symptomatic complications among patients with advanced cancer admitted to acute palliative care units: A prospective observational study
D. Hui (2015)
The accuracy of probabilistic versus temporal clinician prediction of survival for patients with advanced cancer: a preliminary report.
D. Hui (2011)
Models of Palliative Care Delivery for Patients With Cancer.
D. Hui (2020)
Development and cross-validation of the in-hospital mortality prediction in advanced cancer patients score: a preliminary study.
D. Hui (2012)
Palliative care consultation service and palliative care unit: why do we need both?
J. Gaertner (2012)
Patienten mit hämatologischen Grunderkrankungen in der Palliativversorgung
Pauline Elisabeth Hinse (2015)
Prognostic Value of Heart Rate Variability in Patients With Cancer
Y. Guo (2015)
Multimorbidity and aggressiveness of care at the end-of-life among older adults with cancer.
R. Nipp (2017)
Access to palliative care among patients treated at a comprehensive cancer center.
D. Hui (2012)
Care Among Patients Treated at a Comprehensive Cancer Center
David T. Hui (2012)
Clinically Significant Drug-Drug Interactions Involving Medications Used for Symptom Control in Patients With Advanced Malignant Disease: A Systematic Review.
A. Kotlińska-Lemieszek (2019)
Combined effects of Lenvatinib and iodine-131 on cell apoptosis in nasopharyngeal carcinoma through inducing endoplasmic reticulum stress
G. Wang (2018)
Adjunctive immunotherapy enhances antitumor efficacy and improves survival of hepatocellular carcinoma patients
Wan-peng Wang (2017)
Changes in medication profile among patients with advanced cancer admitted to an acute palliative care unit
D. Hui (2014)
Disease-Specific Oncology – Disease-Specific Palliative Care
Joseph A Arthur (2015)
Characteristics of the case mix, organisation and delivery in cancer palliative care: a challenge for good-quality research
M. Hjermstad (2016)
Can early palliative care with anticancer treatment improve overall survival and patient-related outcomes in advanced lung cancer patients? A review of the literature
M. Ambroggi (2018)See more